相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Change in employment status over 52 weeks in patients with schizophrenia: an observational study
C. Kozma et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
P03-341 - Meta-analysis of the efficacy of asenapine for acute schizophrenia: comparisons with placebo and other atypical antipsychotics
A. Szegedi et al.
EUROPEAN PSYCHIATRY (2011)
Efficacy and tolerability of paliperidone ER and other oral atypical antipsychotics in schizophrenia
M.P. Jones et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Meta-analysis: Fact or fiction? How to interpret meta-analyses
Wolfgang Huf et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2011)
Treatment-refractory schizophrenia: what is it and what has been done about it?
Leslie Citrome
NEUROPSYCHIATRY (2011)
Impact of race on efficacy and safety during treatment with olanzapine in schizophrenia, schizophreniform or schizoaffective disorder
Virginia L. Stauffer et al.
BMC PSYCHIATRY (2010)
Measuring Social Functioning With the Personal and Social Performance Scale in Patients With Acute Symptoms of Schizophrenia: Interpretation of Results of a Pooled Analysis of Three Phase III Trials of Paliperidone Extended-Release Tablets
Donald L. Patrick et al.
CLINICAL THERAPEUTICS (2010)
Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone
M. Riedel et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
Christine Rummel-Kluge et al.
SCHIZOPHRENIA RESEARCH (2010)
Graphical displays for meta-analysis: An overview with suggestions for practice
Judith Anzures-Cabrera et al.
RESEARCH SYNTHESIS METHODS (2010)
Meta-analysis of individual participant data: rationale, conduct, and reporting
Richard D. Riley et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Augmentation of clozapine with a second antipsychotic - a meta-analysis of randomized, placebo-controlled studies
D. M. Taylor et al.
ACTA PSYCHIATRICA SCANDINAVICA (2009)
A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia
Stefan Leucht et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making
Jan Volavka et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic
L. Citrome
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Systematic reviews: much ado about a lot
L. Citrome
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic
L. Citrome
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Indirect comparisons of treatments based on systematic reviews of randomised controlled trials
S. J. Edwards et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
The Acute Efficacy of Aripiprazole Across the Symptom Spectrum of Schizophrenia: A Pooled Post Hoc Analysis From 5 Short-Term Studies
Philip G. Janicak et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
How Dosing of Ziprasidone in a State Hospital System Differs From Product Labeling
Leslie Citrome et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Stefan Leucht et al.
LANCET (2009)
How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
S. Leucht et al.
MOLECULAR PSYCHIATRY (2009)
Second-generation antipsychotics for schizophrenia: can we resolve the conflict?
S. Leucht et al.
PSYCHOLOGICAL MEDICINE (2009)
Antipsychotic Combinations vs Monotherapy in Schizophrenia: A Meta-analysis of Randomized Controlled Trials
Christoph U. Correll et al.
SCHIZOPHRENIA BULLETIN (2009)
Dropout Rates in Randomized Clinical Trials of Antipsychotics: A Meta-analysis Comparing First- and Second-Generation Drugs and an Examination of the Role of Trial Design Features
Jonathan Rabinowitz et al.
SCHIZOPHRENIA BULLETIN (2009)
Does the Addition of a Second Antipsychotic Drug Improve Clozapine Treatment?
Corrado Barbui et al.
SCHIZOPHRENIA BULLETIN (2009)
Meta-analysis trends in schizophrenia over three decades
Henry A. Nasrallah
SCHIZOPHRENIA RESEARCH (2009)
Effect of ziprasidone dose on all-cause discontinuation rates in acute schizophrenia and schizoaffective disorder: A post-hoc analysis of 4 fixed-dose randomized clinical trials
Leslie Citrome et al.
SCHIZOPHRENIA RESEARCH (2009)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
PLOS MEDICINE (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Quetiapine - Dose-response relationship in schizophrenia
Anna Sparshatt et al.
CNS DRUGS (2008)
Efficacy and safety of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 52-week open-label studies
Robin Emsley et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2008)
Long-term efficacy and safety of iloperidone - Results from 3 clinical trials for the treatment of schizophrenia
John M. Kane et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Meta-analysis
Anthony N. DeMaria
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Of medicine and meta-analysis
Bethan Hughes
NATURE REVIEWS DRUG DISCOVERY (2008)
The efficacy of aripiprazole in the treatment of multiple symptom domains in patients with acute schizophrenia: A pooled analysis of data from the pivotal trials
John M. Kane et al.
SCHIZOPHRENIA RESEARCH (2008)
Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks
John M. Kane et al.
SCHIZOPHRENIA RESEARCH (2007)
All-cause treatment discontinuation in schizophrenia during treatment with olanzapine relative to other antipsychotics - An integrated analysis
Charles M. Beasley et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Augmentation with a second antipsychotic in patients with schizophrenia who partially respond to clozapine - A meta-analysis
Carol Paton et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Clinical pharmacokinetics of atypical antipsychotics - A critical review of the relationship between plasma concentrations and clinical response
Massimo C. Mauri et al.
CLINICAL PHARMACOKINETICS (2007)
Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia
Bruce J. Kinon et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Basic concepts in meta-analysis: a primer for clinicians
A. Khoshdel et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Estimating transitions between symptom severity states over time in schizophrenia: a Bayesian meta-analytic approach
Anirban Basu et al.
STATISTICS IN MEDICINE (2006)
Risperidone augmentation of clozapine - A critical review
Vassilis P. Kontaxakis et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2006)
Aripiprazole for schizophrenia - Systematic review
H. G. El-Sayeh et al.
BRITISH JOURNAL OF PSYCHIATRY (2006)
Schizophrenia, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and number needed to treat: how can CATIE inform clinicians?
L. Citrome et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review
Allen E. Thornton et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
A meta-analysis of profile and time-course of symptom change in acute schizophrenia treated with atypical antipsychotics
Megan Sherwood et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)
Meta-analysis of drop-out rates in randomised clinical trials, comparing typical and atypical antipsychotics in the treatment of schizophrenia
JLR Martin et al.
EUROPEAN PSYCHIATRY (2006)
Establishing a dose-response relationship for oral risperidone in relapsed schizophrenia
N Ezewuzie et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs - A meta-analysis
G Kemmler et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Dosing of quetiapine in schizophrenia: How clinical practice differs from registration studies
L Citrome et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Efficacy of aripiprazole against hostility in schizophrenia and Schizoaffective disorder: Data from 5 double-blind studies
J Volavka et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Dosing of second-generation antipsychotic medication in a state hospital system
L Citrome et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
The crossover approach to switching antipsychotics: What is the evidence?
G Remington et al.
SCHIZOPHRENIA RESEARCH (2005)
Using Metaanalysis to Evaluate Evidence: Practical Tips and Traps
Raymond W. Lam et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2005)
A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia
ND Woodward et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2005)
Old versus new: weighing the evidence between the firstand second-generation antipsychotics
JM Davis et al.
EUROPEAN PSYCHIATRY (2005)
Dose response and dose equivalence of antipsychotics
JM Davis et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials
PF Buckley
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Clozapine v. conventional antipsychotic drugs for treatment-resistant schizophrenia: a re-examination
J Moncrieff
BRITISH JOURNAL OF PSYCHIATRY (2003)
The efficacy of quetiapine vs. haloperidol and placebo: a meta-analytic study of efficacy
SC Schulz et al.
SCHIZOPHRENIA RESEARCH (2003)
Relapse prevention in schizophrenia with new-generation antipsychotics: A systematic review and exploratory meta-analysis of randomized, controlled trials
S Leucht et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
A meta-analysis of the efficacy of second-generation antipsychotics
JM Davis et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-manalysis
S Leucht et al.
LANCET (2003)
Clinical trial response and dropout rates with olanzapine versus risperidone
B Santarlasci et al.
ANNALS OF PHARMACOTHERAPY (2003)
Optimal dosing of atypical antipsychotics in adults: A review of the current evidence.
L Citrome et al.
HARVARD REVIEW OF PSYCHIATRY (2002)
Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized trials
A Tuunainen et al.
SCHIZOPHRENIA RESEARCH (2002)
Comparing the efficacy of atypical antipsychotics in open uncontrolled versus double-blind controlled trials in schizophrenia
FG Pajonk et al.
PSYCHOPHARMACOLOGY (2002)
Clinical profile of an atypical antipsychotic: Risperidone
JM Davis et al.
SCHIZOPHRENIA BULLETIN (2002)
The effects of olanzapine on the 5 dimensions of schizophrenia derived by factor analysis: Combined results of the North American and international trials
JM Davis et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Treatment of the symptoms of schizophrenia: a combined analysis of double-blind studies comparing risperidone with haloperidol and other antipsychotic agents
ID Glick et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2001)
Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials
A Aleman et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2001)
Meta-analysis comparing newer antipsychotic drugs for the treatment of schizophrenia: Evaluating the indirect approach
L Sauriol et al.
CLINICAL THERAPEUTICS (2001)
Dropout rates in randomised antipsychotic drug trials
K Wahlbeck et al.
PSYCHOPHARMACOLOGY (2001)
Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: A review and meta-analysis of randomized trials
M Chakos et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Consistency of atypical antipsychotic superiority to placebo in recent clinical trials
SW Woods et al.
BIOLOGICAL PSYCHIATRY (2001)
Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis
J Geddes et al.
BRITISH MEDICAL JOURNAL (2000)
Effects of risperidone on affective symptoms in patients with schizophrenia
J Peuskens et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2000)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Refractory schizophrenia and atypical antipsychotics
DM Taylor et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2000)
分享论文
